Vesilute 20 mg

Steroids Dragon Pharma Peptide

$26.40

Vesilute 20 mg – Bladder Tissue Peptide Bioregulator | Peptide Hubs

Vesilute is a synthetic peptide bioregulator designed for bladder and lower urinary tract tissue support. This 20 mg (2 mL) vial by Peptide Hubs is offered as a high-purity compound for experimental use in studies involving epithelial regeneration, urinary function, and age-related decline of bladder tissue. It mimics natural peptides derived from bladder tissue and is used in research investigating organ-specific cellular regeneration.

What Is Vesilute?

Vesilute is part of a class of peptides known as cytomedines—organ-specific bioregulators that target gene expression and cellular renewal in specific tissues. In this case, Vesilute is studied for its effects on bladder urothelial lining, detrusor muscle tone, and urinary tract epithelium. Research indicates it may support tissue restoration, reduce inflammation, and normalize voiding functions.

According to studies on peptide bioregulators, compounds like Vesilute may play a role in epigenetic modulation, helping restore normal cellular functions in aging or damaged organs.

Key Research Applications

Bladder tissue repair and regeneration
Normalization of urothelial function
Support in urinary incontinence and LUTS models
Anti-inflammatory support in urological tissue
Anti-aging applications for urinary tract health

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:

Steroids

Brand: Dragon Pharma

Manufacturer: Dragon Pharma

Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage & Usage Guidelines</h2> <p>In research settings, Vesilute is typically dosed at <strong>10–20 mg per week</strong>, administered subcutaneously in 2–3 injections per week. Research duration may vary from 2 to 6 weeks depending on tissue regeneration goals and study design. The peptide is non-hormonal and acts through localized gene expression influence.</p> <h3>Suggested Peptide Combinations for Research</h3> <p>To expand the regenerative potential of Vesilute, researchers often combine it with other tissue- or neuro-supportive peptides:</p> <ul> <li>BPC-157 – promotes tissue healing and anti-inflammatory action</li> <li>GHK-Cu – supports angiogenesis and connective tissue repair</li> <li>Selank – for neuroimmune support in pelvic floor and urogenital studies</li> <li>Thymalin – immune-endocrine balance and systemic peptide support</li> <li>AOD 9604 – supports metabolic recovery and organ peptide synergy</li> </ul> <h3>Safety Profile</h3> <p>Vesilute has demonstrated excellent safety in preclinical research. It does not interfere with hormonal pathways, nor does it cause hepatotoxicity or cardiovascular stress. Being an organ-targeted bioregulator, it is systemically neutral and has no androgenic or estrogenic effects. It is designated for laboratory research use only and is not approved for human use.</p> <h3>USA Domestic Shipping | GMP Quality</h3> <p>Peptide Hubs ensures rapid and secure <strong>USA domestic shipping</strong> of Vesilute 20 mg and all bioregulator peptides. Each batch is produced under strict GMP standards. For researchers investigating bladder health, urothelial repair, or age-related urinary issues, Vesilute is a well-supported addition to the peptide toolkit.</p> </section> </div>

Reviews:

(0 customer reviews)